Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **DNA minor groove at GC-rich regions** refers to a specific structural feature within double-stranded B-form DNA. The "minor groove" is one of two grooves that spiral around the helical axis; it is narrower and less accessible than the major groove. The width and chemical environment of this region are strongly influenced by base composition—GC pairs create a wider, less electronegative, and more rigid minor groove compared with AT pairs, which have a narrower, more flexible profile. Certain small molecules—most notably some antitumor antibiotics such as **chromomycin A3**—selectively bind in the **minor grooves** at **GC-rich sequences**, often requiring divalent metal ions for stable complex formation. This interaction can alter local DNA conformation by widening the minor groove and compressing adjacent regions. Such changes can disrupt normal protein-DNA interactions required for transcription or replication, thereby exerting therapeutic effects in cancer but also posing risks for toxicity if off-target genes are affected. While most classical "minor-groove binders" prefer AT tracts due to their narrowness and favorable electrostatics (e.g., distamycin), certain natural products like chromomycin A3 exhibit high affinity for specific short runs rich in G-C content such as TGGCCA motifs. These drugs act primarily through reversible non-covalent interactions but may also induce conformational changes that inhibit RNA synthesis or other essential processes in rapidly dividing cells such as cancer cells. In summary, while not a protein receptor or enzyme itself, this structural feature serves as an important drug-binding site relevant both therapeutically (notably in oncology) and mechanistically for understanding nucleic acid recognition by small molecules.
Non-covalent binding to the DNA minor groove at GC-rich sequences, leading to widening of the minor groove and compression of the major groove; Inhibition or modulation of transcription by altering local chromatin/DNA structure.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA minor groove at GC-rich region.